Sila Realty Trust Inc Dossier - Source-backed chat

Sila Realty Trust Inc

SILANYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

Beta (adjusted)0.55

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $30.36Price as of 30 Jun 2026

Data confidence Sign in to view data confidence

Market Cap $1.7B

Enterprise Value $2.3B

Shares Outstanding 55.3M diluted

Last ex-dividend20 May 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Sila Realty Trust, Inc. (NYSE: SILA) is currently in a definitive agreement to be acquired by affiliates of Blue Owl Capital Inc. (specifically Sunshine Ultimate Parent LLC and Sunshine Holding REIT LLC) in an all-cash transaction valued at approximately $2.4 billion. Under the terms of the merger agreement signed on April 19, 2026, stockholders will receive $30.38 in cash per share. This represents a 19.0% premium to Sila's closing stock price of $25.53 on April 17, 2026. Given that the stock is trading very close to the acquisition price (around $30.25 to $30.28) and the transaction is expected to close in the second or third quarter of 2026 subject to the stockholder vote on June 26, 2026, a 'Hold' recommendation is highly appropriate. The downside risk is limited by the cash floor of the deal, while upside is capped at the $30.38 acquisition price, making it a classic merger arbitrage situation with low remaining spread.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$30.00

Mean target$30.25

High · most bullish analyst$31.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Stockholders reject the merger, or pending shareholder litigation/demand letters successfully disrupt or delay the transaction. Sila remains an independent public company. The stock price likely falls back toward its pre-announcement trading range of $23.00 to $25.50, reflecting the loss of the merger premium, though supported by its solid healthcare real estate fundamentals and ~5.3% dividend yield.

Base CaseCentral scenario

The merger is approved by Sila's stockholders at the Special Meeting on June 26, 2026, and successfully closes in Q2 or Q3 2026. Stockholders receive the agreed-upon cash consideration of $30.38 per share, and the company is taken private, delisting from the NYSE.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Definitive take-private agreement provides a clear cash exit at $30.38 per share, representing a 19% premium over the pre-announcement price.
High-quality, defensive net-lease healthcare portfolio with 98.7% occupancy and a long weighted average remaining lease term of 10.1 years.
Strong balance sheet with net debt to enterprise value of approximately 33.4% and no near-term debt maturities until 2027.

Key Investment Risks

Deal failure risk if stockholders do not approve the transaction at the June 26, 2026 meeting.
Litigation risk from outstanding shareholder complaints and demand letters alleging disclosure deficiencies in the proxy materials.
Opportunity cost of capital tied up in a stock with capped upside and a very tight arbitrage spread.

Thesis Invalidation Triggers

Rejection of the merger proposal by Sila's stockholders at the June 26, 2026 Special Meeting.
Regulatory or legal intervention that blocks or indefinitely delays the closing of the transaction.
Mutual termination of the merger agreement by Sila and Blue Owl affiliates.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.